Design and validation of a consistent and reproducible manufacture process for the production of clinical-grade bone marrow–derived multipotent mesenchymal stromal cells-Reference-Cited by-同舟云学术

Design and validation of a consistent and reproducible manufacture process for the production of clinical-grade bone marrow–derived multipotent mesenchymal stromal cells

Published:2016-09 Issue:9 Volume:18 Page:1197-1208
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Codinach Margarita,Blanco Margarita,Ortega Isabel,Lloret Mireia,Reales Laura,Coca Maria Isabel,Torrents Sílvia,Doral Manel,Oliver-Vila Irene,Requena-Montero Miriam,Vives Joaquim,Garcia-López Joan

Funder

Ministerio de Economía y Competitividad

Ministerio de Ciencia e Innovación

Spanish Cell Therapy Network

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference28 articles.

1. Therapeutic human cells: manufacture for cell therapy/regenerative medicine;van den Bos;Adv Biochem Eng Biotechnol,2014

2. Will regenerative medicine replace transplantation?;Orlando;Cold Spring Harb Perspect Med,2013

3. Cell therapy companies make strong progress from October 2012 to March 2013 amid mixed stock market sentiment;Mason;Cell Stem Cell,2013